Orna Therapeutics

United States
Primghar, Iowa, United States, 02139

Company profile

Orna Therapeutics company profile

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way they treat disease. The company's proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Founded
2019-01-01, Year

Headquarters

Postal code
02139
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
3
Total equity funding
$321M
Last funding
Series B / $221M / 2022-08-16
Last equity funding
Series B / $221M
Investors
10
Lead investors
4
Founders
3
Articles
89
Exited on
2026-02-09

Founders and investors

Founders

Alex WesselhoeftDaniel AndersonRaffaella Squilloni

Lead investors

F2 VenturesMerckMPM CapitalTaiho Ventures

Investors

Bristol-Myers SquibbKite PharmaMerckMPM CapitalTaiho Ventures